Ghost Tree Capital »

Korro Bio shares owned by Ghost Tree Capital

Quarter-by-quarter ownership of Korro Bio (KRRO) shares owned by Ghost Tree Capital from 13F filings

Historical chart of Ghost Tree Capital investment in Korro Bio

Tip: Access up to 7 years of quarterly data

All positions including Korro Bio held by Ghost Tree Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Korro Bio by Ghost Tree Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $3.4M 100k 33.87

More positions owned by Ghost Tree Capital

Alnylam Pharmaceuticals (ALNY)
Insmed Com Par $.01 (INSM)
Biohaven (BHVN)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Soleno Therapeutics (SLNO)
Axsome Therapeutics (AXSM)
Ascendis Pharma A/s Sponsored Adr (ASND)
Vaxcyte (PCVX)
Crinetics Pharmaceuticals In (CRNX)
Roivant Sciences SHS (ROIV)
Perspective Therapeutics Com New (CATX)
Tg Therapeutics (TGTX)
Sarepta Therapeutics (SRPT)
Cg Oncology (CGON)
Corbus Pharmaceuticals Hldgs Com New (CRBP)

View all positions for Ghost Tree Capital

Top funds holding Korro Bio

Atlas Venture Life Science Advisors
NEA Management Company
Deep Track Capital
Citadel Advisors
Vanguard Group
BlackRock
Point72 Asset Management
Siren
BlackRock
Eventide Asset Management
Qiming U.S. Ventures Management
72 Investment Holdings
Cormorant Asset Management
Driehaus Capital Management
Schonfeld Strategic Advisors

View all funds holding Korro Bio